Autosomal recessive HOXA3 deficiency causes congenital athymia and laryngeal malformation.

IF 11.7 1区 医学 Q1 ALLERGY
Sarah S Dinges, Marita Bosticardo, Anke Hirschfelder, Francesca Pala, Johannes Kopp, Viktor Glaser, Johannes Gru Nhagen, Giuseppe Sangiorgio, Lisa Ehlers, Pawel Durek, Olga Staudacher, Mirjam Völler, Austen Worth, Uwe Kölsch, Zainab M Golwala, Nadine Unterwalder, Erwin Lankes, Karl-Ulrich Schunck, Frederik Heinrich, Kayla Amini, Stavros Loukogeorgakis, Evey Howley, Heather Kenney, Hendrik S Fischer, Sven C Weber, Oliver Blankenstein, Christian Meisel, Anke Wendt, Harald Stachelscheid, Angela Kaindl, Christoph Bu Hrer, Anita Balázs, Mir-Farzin Mashreghi, Julia K Polansky, Dimitrios L Wagner, E Graham Davies, Marcus A Mall, Alexandra Y Kreins, Luigi D Notarangelo, Horst von Bernuth
{"title":"Autosomal recessive HOXA3 deficiency causes congenital athymia and laryngeal malformation.","authors":"Sarah S Dinges, Marita Bosticardo, Anke Hirschfelder, Francesca Pala, Johannes Kopp, Viktor Glaser, Johannes Gru Nhagen, Giuseppe Sangiorgio, Lisa Ehlers, Pawel Durek, Olga Staudacher, Mirjam Völler, Austen Worth, Uwe Kölsch, Zainab M Golwala, Nadine Unterwalder, Erwin Lankes, Karl-Ulrich Schunck, Frederik Heinrich, Kayla Amini, Stavros Loukogeorgakis, Evey Howley, Heather Kenney, Hendrik S Fischer, Sven C Weber, Oliver Blankenstein, Christian Meisel, Anke Wendt, Harald Stachelscheid, Angela Kaindl, Christoph Bu Hrer, Anita Balázs, Mir-Farzin Mashreghi, Julia K Polansky, Dimitrios L Wagner, E Graham Davies, Marcus A Mall, Alexandra Y Kreins, Luigi D Notarangelo, Horst von Bernuth","doi":"10.1016/j.jaci.2026.09.010","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Approximately 10% of patients with Severe Combined Immunodeficiency (SCID) phenotype lack a known genetic cause. In particular, the molecular basis of thymic defects is poorly understood. Homeobox (HOX) genes encode conserved transcription factors that control spatial body development. The function of human HOXA3 is undefined.</p><p><strong>Objective: </strong>We characterize the first human with HOXA3 deficiency and investigate the role of HOXA3 in immune system development.</p><p><strong>Methods: </strong>We performed clinical and immunological phenotyping, as well as genetic sequencing. A homozygous nonsense variant in HOXA3 was identified, and functionally validated including RT-PCR, western blot, assessment of transcriptional activity and intracellular localization of HOXA3. We report clinical management and course.</p><p><strong>Results: </strong>The homozygous HOXA3 nonsense variant generates a truncated protein with cytoplasmic retention and reduced transcriptional activity. The clinical phenotype includes craniofacial and cervical anomalies, severe laryngopharyngeal malformation with epiglottic hypoplasia causing dysphagia and aspiration, central breathing disorder, and thymus aplasia. T-cell maturation in artificial thymic organoids (ATO) and recovery after thymus transplantation establish the T-cell defect as non-hematopoietic.</p><p><strong>Conclusion: </strong>Human HOXA3 has non-redundant roles for the development of larynx and thymus. HOXA3 deficiency is a novel, life-threatening multisystem disorder. It is the first human Homeobox-gene disease causing congenital athymia. These findings expand the diagnostic gene panel for patients with a SCID phenotype and indicate epiglottic hypoplasia as a new specific co-morbidity of congenital athymia.</p><p><strong>Key messages: </strong>Homeobox A3 (HOXA3) deficiency is a novel cause of congenital athymia, characterized by craniofacial and cervical anomalies, and life-threatening laryngeal malformation. Human HOXA3, unlike murine Hoxa3, may be redundant for parathyroid and thyroid gland development. The loss of the homeodomain causes cytoplasmic retention of the HOXA3 protein, leading to reduced transcriptional activity.</p><p><strong>Capsule summary: </strong>We describe HOXA3 deficiency as the 8<sup>th</sup> genetically defined cause of congenital athymia, facilitating life-saving thymus transplantation for future patients. Life-threatening laryngeal malformations provide a clinical diagnostic clue for congenital athymia.</p>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":" ","pages":""},"PeriodicalIF":11.7000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaci.2026.09.010","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Approximately 10% of patients with Severe Combined Immunodeficiency (SCID) phenotype lack a known genetic cause. In particular, the molecular basis of thymic defects is poorly understood. Homeobox (HOX) genes encode conserved transcription factors that control spatial body development. The function of human HOXA3 is undefined.

Objective: We characterize the first human with HOXA3 deficiency and investigate the role of HOXA3 in immune system development.

Methods: We performed clinical and immunological phenotyping, as well as genetic sequencing. A homozygous nonsense variant in HOXA3 was identified, and functionally validated including RT-PCR, western blot, assessment of transcriptional activity and intracellular localization of HOXA3. We report clinical management and course.

Results: The homozygous HOXA3 nonsense variant generates a truncated protein with cytoplasmic retention and reduced transcriptional activity. The clinical phenotype includes craniofacial and cervical anomalies, severe laryngopharyngeal malformation with epiglottic hypoplasia causing dysphagia and aspiration, central breathing disorder, and thymus aplasia. T-cell maturation in artificial thymic organoids (ATO) and recovery after thymus transplantation establish the T-cell defect as non-hematopoietic.

Conclusion: Human HOXA3 has non-redundant roles for the development of larynx and thymus. HOXA3 deficiency is a novel, life-threatening multisystem disorder. It is the first human Homeobox-gene disease causing congenital athymia. These findings expand the diagnostic gene panel for patients with a SCID phenotype and indicate epiglottic hypoplasia as a new specific co-morbidity of congenital athymia.

Key messages: Homeobox A3 (HOXA3) deficiency is a novel cause of congenital athymia, characterized by craniofacial and cervical anomalies, and life-threatening laryngeal malformation. Human HOXA3, unlike murine Hoxa3, may be redundant for parathyroid and thyroid gland development. The loss of the homeodomain causes cytoplasmic retention of the HOXA3 protein, leading to reduced transcriptional activity.

Capsule summary: We describe HOXA3 deficiency as the 8th genetically defined cause of congenital athymia, facilitating life-saving thymus transplantation for future patients. Life-threatening laryngeal malformations provide a clinical diagnostic clue for congenital athymia.

常染色体隐性HOXA3缺陷导致先天性胸腺炎和喉畸形。
背景:大约10%的严重联合免疫缺陷(SCID)表型患者缺乏已知的遗传原因。特别是,胸腺缺陷的分子基础尚不清楚。同源盒(HOX)基因编码控制空间体发育的保守转录因子。人类HOXA3的功能尚不明确。目的:对首例HOXA3缺陷患者进行鉴定,探讨HOXA3在免疫系统发育中的作用。方法:我们进行了临床和免疫表型分析,以及基因测序。鉴定出HOXA3的纯合无义变异,并通过RT-PCR、western blot、转录活性评估和HOXA3的细胞内定位进行功能验证。我们报告临床管理和疗程。结果:纯合子HOXA3无义变异体产生一个截断的蛋白,具有细胞质保留和转录活性降低。临床表型包括颅面和颈部异常,严重的喉咽畸形伴会厌发育不全导致吞咽困难和吸入,中枢性呼吸障碍和胸腺发育不全。人工胸腺类器官(ATO)中的t细胞成熟和胸腺移植后的恢复证实了t细胞的非造血缺陷。结论:人HOXA3在喉部和胸腺的发育中具有非冗余作用。HOXA3缺乏症是一种新的危及生命的多系统疾病。它是第一个人类同源箱基因疾病引起先天性胸腺。这些发现扩大了SCID表型患者的诊断基因范围,并表明会厌发育不全是先天性胸腺功能不全的一种新的特异性合并症。关键信息:同源盒A3 (HOXA3)缺乏是先天性胸腺功能不全的新原因,其特征是颅面和颈部异常,以及危及生命的喉畸形。与小鼠的HOXA3不同,人类的HOXA3对于甲状旁腺和甲状腺的发育可能是多余的。同源结构域的缺失导致HOXA3蛋白的细胞质保留,导致转录活性降低。我们将HOXA3缺乏描述为先天性胸腺不全的第8个遗传原因,为未来患者提供挽救生命的胸腺移植。危及生命的喉部畸形为先天性胸腺疾患提供了临床诊断线索。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
25.90
自引率
7.70%
发文量
1302
审稿时长
38 days
期刊介绍: The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书